Cara L Carty1, Charles Kooperberg2, Jingmin Liu2, Megan Herndon2, Themistocles Assimes2, Lifang Hou2, Candyce H Kroenke2, Andrea Z LaCroix2, Masayuki Kimura2, Abraham Aviv2, Alexander P Reiner2. 1. From the Division of Biostatistics and Study Methodology, Center for Translational Science, George Washington University and Children's National Medical Center, Washington, DC (C.L.C.); Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA (C.K., J.L., M.H., A.P.R.); Department of Medicine, Stanford University School of Medicine, Palo Alto, CA (T.A.); Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL (L.H.); Kaiser Permanente Division of Research, Oakland, CA (C.H.K.); Department of Epidemiology, University of California, San Diego (A.Z.L.); Center of Development and Aging, New Jersey Medical School, Rutgers State University of New Jersey, Newark (M.K., A.A.); and Department of Epidemiology, University of Washington, Seattle (A.P.R.). ccarty@cnmc.org. 2. From the Division of Biostatistics and Study Methodology, Center for Translational Science, George Washington University and Children's National Medical Center, Washington, DC (C.L.C.); Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA (C.K., J.L., M.H., A.P.R.); Department of Medicine, Stanford University School of Medicine, Palo Alto, CA (T.A.); Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL (L.H.); Kaiser Permanente Division of Research, Oakland, CA (C.H.K.); Department of Epidemiology, University of California, San Diego (A.Z.L.); Center of Development and Aging, New Jersey Medical School, Rutgers State University of New Jersey, Newark (M.K., A.A.); and Department of Epidemiology, University of Washington, Seattle (A.P.R.).
Abstract
OBJECTIVE: Telomeres are regions at the ends of chromosomes that maintain chromosomal structural integrity and genomic stability. In studies of mainly older, white populations, shorter leukocyte telomere length (LTL) is associated with cardiometabolic risk factors and increased risks of mortality and coronary heart disease (CHD). On average, African Americans (AfAm) have longer LTL than whites, but the LTL-CHD relationship in AfAm is unknown. We investigated the relationship of LTL with CHD and mortality among AfAm. APPROACH AND RESULTS: Using a case-cohort design, 1525 postmenopausal women (667 AfAm and 858 whites) from the Women's Health Initiative had LTL measured in baseline blood samples by Southern blotting. CHD or mortality hazards ratios were estimated using race-stratified and risk factor-adjusted Cox proportional hazards models. There were 367 incident CHD (226 mortality) events in whites, whereas AfAm experienced 269 incident CHD (216 mortality) events during median follow-up of 13 years. Shorter LTL was associated with older age, current smoking, and white race/ethnicity. In whites, each 1 kilobase decrease in LTL was associated with 50% increased hazard of CHD, hazard ratio=1.50 (95% confidence interval, 1.08-2.10), P=0.017. There was no association between CHD and LTL in AfAm. White women with shorter LTL had higher risks of mortality. In contrast, shorter LTL was weakly associated with decreased mortality hazard in AfAm. CONCLUSIONS: As one of the largest prospective studies of LTL associations with incident CHD and mortality in a racially diverse sample, our study suggests differences in LTL associations with CHD and mortality between white and AfAm postmenopausal women.
OBJECTIVE: Telomeres are regions at the ends of chromosomes that maintain chromosomal structural integrity and genomic stability. In studies of mainly older, white populations, shorter leukocyte telomere length (LTL) is associated with cardiometabolic risk factors and increased risks of mortality and coronary heart disease (CHD). On average, African Americans (AfAm) have longer LTL than whites, but the LTL-CHD relationship in AfAm is unknown. We investigated the relationship of LTL with CHD and mortality among AfAm. APPROACH AND RESULTS: Using a case-cohort design, 1525 postmenopausal women (667 AfAm and 858 whites) from the Women's Health Initiative had LTL measured in baseline blood samples by Southern blotting. CHD or mortality hazards ratios were estimated using race-stratified and risk factor-adjusted Cox proportional hazards models. There were 367 incident CHD (226 mortality) events in whites, whereas AfAm experienced 269 incident CHD (216 mortality) events during median follow-up of 13 years. Shorter LTL was associated with older age, current smoking, and white race/ethnicity. In whites, each 1 kilobase decrease in LTL was associated with 50% increased hazard of CHD, hazard ratio=1.50 (95% confidence interval, 1.08-2.10), P=0.017. There was no association between CHD and LTL in AfAm. White women with shorter LTL had higher risks of mortality. In contrast, shorter LTL was weakly associated with decreased mortality hazard in AfAm. CONCLUSIONS: As one of the largest prospective studies of LTL associations with incident CHD and mortality in a racially diverse sample, our study suggests differences in LTL associations with CHD and mortality between white and AfAm postmenopausal women.
Authors: A M Valdes; T Andrew; J P Gardner; M Kimura; E Oelsner; L F Cherkas; A Aviv; T D Spector Journal: Lancet Date: 2005 Aug 20-26 Impact factor: 79.321
Authors: Stacy S Drury; Kyle Esteves; Virginia Hatch; Margaret Woodbury; Sophie Borne; Alys Adamski; Katherine P Theall Journal: J Pediatr Date: 2015-02-11 Impact factor: 4.406
Authors: Steven C Hunt; Masayuki Kimura; Paul N Hopkins; J Jeffrey Carr; Gerardo Heiss; Michael A Province; Abraham Aviv Journal: Am J Cardiol Date: 2015-04-18 Impact factor: 2.778
Authors: Joris Deelen; Marian Beekman; Veryan Codd; Stella Trompet; Linda Broer; Sara Hägg; Krista Fischer; Peter E Thijssen; H Eka D Suchiman; Iris Postmus; André G Uitterlinden; Albert Hofman; Anton J M de Craen; Andres Metspalu; Nancy L Pedersen; Cornelia M van Duijn; J Wouter Jukema; Jeanine J Houwing-Duistermaat; Nilesh J Samani; P Eline Slagboom Journal: Int J Epidemiol Date: 2014-01-14 Impact factor: 7.196
Authors: Tsuyoshi Hamada; Chen Yuan; Shuji Ogino; Brian M Wolpin; Ying Bao; Mingfeng Zhang; Natalia Khalaf; Ana Babic; Vicente Morales-Oyarvide; Barbara B Cochrane; J Michael Gaziano; Edward L Giovannucci; Peter Kraft; JoAnn E Manson; Kimmie Ng; Jonathan A Nowak; Thomas E Rohan; Howard D Sesso; Meir J Stampfer; Laufey T Amundadottir; Charles S Fuchs; Immaculata De Vivo Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-08-19 Impact factor: 4.254
Authors: Stanford Mwasongwe; Yan Gao; Michael Griswold; James G Wilson; Abraham Aviv; Alexander P Reiner; Laura M Raffield Journal: Atherosclerosis Date: 2017-09-15 Impact factor: 5.162
Authors: Matthew E B Hansen; Steven C Hunt; Rivka C Stone; Kent Horvath; Utz Herbig; Alessia Ranciaro; Jibril Hirbo; William Beggs; Alexander P Reiner; James G Wilson; Masayuki Kimura; Immaculata De Vivo; Maxine M Chen; Jeremy D Kark; Daniel Levy; Thomas Nyambo; Sarah A Tishkoff; Abraham Aviv Journal: Hum Mol Genet Date: 2016-03-02 Impact factor: 6.150
Authors: Laurie Grieshober; Jean Wactawski-Wende; Rachael Hageman Blair; Lina Mu; Jingmin Liu; Jing Nie; Cara L Carty; Lauren Hale; Candyce H Kroenke; Andrea Z LaCroix; Alex P Reiner; Heather M Ochs-Balcom Journal: Am J Epidemiol Date: 2019-09-01 Impact factor: 4.897
Authors: Pam Factor-Litvak; Ezra Susser; Katrina Kezios; Ian McKeague; Jeremy D Kark; Matthew Hoffman; Masayuki Kimura; Ronald Wapner; Abraham Aviv Journal: Pediatrics Date: 2016-03-11 Impact factor: 7.124
Authors: Jennifer A Doherty; Laurie Grieshober; John R Houck; Matthew J Barnett; Jean De Dieu Tapsoba; Mark Thornquist; Ching-Yun Wang; Gary E Goodman; Chu Chen Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-05-09 Impact factor: 4.254
Authors: Catherine L Callahan; Marian Pavuk; Linda S Birnbaum; Xuefeng Ren; James R Olson; Matthew R Bonner Journal: Environ Int Date: 2017-09-05 Impact factor: 9.621